Optimizing lyophilization primary drying: A vaccine case study with experimental and modeling techniques.
Autor: | Najarian J; Merck & Co., Inc., Rahway, NJ 07065, USA. Electronic address: jeff_najarian@merck.com., Metsi-Guckel E; Merck & Co., Inc., Rahway, NJ 07065, USA. Electronic address: fay.metsi-guckel@merck.com., Renawala HK; Merck & Co., Inc., Rahway, NJ 07065, USA., Grosse D; Merck & Co., Inc., Rahway, NJ 07065, USA., Sims A; Merck & Co., Inc., Rahway, NJ 07065, USA., Walter A; Merck & Co., Inc., Rahway, NJ 07065, USA., Sarkar A; Merck & Co., Inc., Rahway, NJ 07065, USA., Karande A; Merck & Co., Inc., Rahway, NJ 07065, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of pharmaceutics [Int J Pharm] 2024 Jun 25; Vol. 659, pp. 124168. Date of Electronic Publication: 2024 Apr 24. |
DOI: | 10.1016/j.ijpharm.2024.124168 |
Abstrakt: | In this study, we present the lyophilization process development efforts for a vaccine formulation aimed at optimizing the primary drying time (hence, the total cycle length) through comprehensive evaluation of its thermal characteristics, temperature profile, and critical quality attributes (CQAs). Differential scanning calorimetry (DSC) and freeze-drying microscopy (FDM) were used to experimentally determine the product-critical temperatures, viz., the glass transition temperature (T Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2024 Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |